This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Henkels, K. M. Articles by Turchi, J. J. Search for Related Content PubMed PubMed Citation Articles by Henkels, K. M. Articles by Turchi, J. J.

Induction of Apoptosis in Cisplatin-sensitive and -resistant Human Ovarian Cancer Cell Lines¹

Department of Biochemistry and Molecular Biology, Wright State University School of Medicine, Dayton, Ohio 45435

In this study, we have assessed the mechanism of cytotoxicity in a series of cisplatin-sensitive and -resistant ovarian carcinoma cells following treatment with equitoxic concentrations of cisplatin. The specific proteolytic degradation and the enzymatic activities of the DNA-dependent protein kinase (DNA-PK) were assessed in the cisplatin-sensitive A2780 cell line and two resistant derivative cell lines, CP70 and C30. Forty-eight h following cisplatin treatment, unattached, apoptotic A2780 cells demonstrated a 20–30% decrease in DNA-PK phosphorylation activity. The resistant CP70 and C30 cell lines showed greater decreases in activity approaching 80 and 90%, respectively. The decreases in kinase activity were attributed to proteolytic degradation of the catalytic subunit of DNA-PK (DNA-PKcs). The extent of degradation mimicked the loss of DNA-PK activity, with the resistant cell lines showing the greatest portion of degraded DNA-PKcs. At the same time point, the ability of the DNA-PK Ku subunits to bind DNA was decreased in apoptotic, unattached cells compared to untreated controls, with the decrease in binding activity being attributed to decreased expression of the Ku subunits. In addition to DNA-PKcs cleavage, specific proteolytic cleavage of the poly (ADP-ribose)-polymerase and generation of nucleosome-length DNA ladders was observed in all cell lines following cisplatin treatment. These data suggest that cell death via the accumulation of cisplatin-damaged DNA occurs via apoptosis in both the cisplatin-resistant and -sensitive ovarian cancer cells.

¹ This work was supported by NIH Award CA64374 (to J. J. T.).

² To whom requests for reprints should be addressed, at Department of Biochemistry and Molecular Biology, Wright State University, 3640 Colonel Glenn Highway, Dayton, OH 45435. Phone: (937) 775-2853; Fax: (937) 775-3730; E-mail: jturchi@wright.edu.

Received 7/22/97. Accepted 8/29/97.

This article has been cited by other articles:

				L. Cao, D. N. Petrusca, M. Satpathy, H. Nakshatri, I. Petrache, and D. Matei Tissue transglutaminase protects epithelial ovarian cancer cells from cisplatin-induced apoptosis by promoting cell survival signaling Carcinogenesis, October 1, 2008; 29(10): 1893 - 1900. [Abstract] [Full Text] [PDF]

				H. J. Boeckman, K. S. Trego, and J. J. Turchi Cisplatin Sensitizes Cancer Cells to Ionizing Radiation via Inhibition of Nonhomologous End Joining Mol. Cancer Res., May 1, 2005; 3(5): 277 - 285. [Abstract] [Full Text] [PDF]

				J. Feng, J. Park, P. Cron, D. Hess, and B. A. Hemmings Identification of a PKB/Akt Hydrophobic Motif Ser-473 Kinase as DNA-dependent Protein Kinase J. Biol. Chem., September 24, 2004; 279(39): 41189 - 41196. [Abstract] [Full Text] [PDF]

				M. B. Flick, D. O'Malley, T. Rutherford, S. Rodov, M. Kamsteeg, X.-Y. Hao, P. Schwartz, B. M. Kacinski, and G. Mor Apoptosis-Based Evaluation of Chemosensitivity in Ovarian Cancer Patients Reproductive Sciences, May 1, 2004; 11(4): 252 - 259. [Abstract] [PDF]

				P. A. Nguewa, M. A. Fuertes, C. Alonso, and J. M. Perez Pharmacological Modulation of Poly(ADP-ribose) Polymerase-Mediated Cell Death: Exploitation in Cancer Chemotherapy Mol. Pharmacol., November 1, 2003; 64(5): 1007 - 1014. [Full Text] [PDF]

				L. Fourrier, P. Brooks, and J.-M. Malinge Binding Discrimination of MutS to a Set of Lesions and Compound Lesions (Base Damage and Mismatch) Reveals Its Potential Role as a Cisplatin-damaged DNA Sensing Protein J. Biol. Chem., May 30, 2003; 278(23): 21267 - 21275. [Abstract] [Full Text] [PDF]

				S. I. Mohammed, B. A. Craig, A. J. Mutsaers, N. W. Glickman, P. W. Snyder, A. E. deGortari, D. L. Schlittler, K. T. Coffman, P. L. Bonney, and D. W. Knapp Effects of the Cyclooxygenase Inhibitor, Piroxicam, in Combination with Chemotherapy on Tumor Response, Apoptosis, and Angiogenesis in a Canine Model of Human Invasive Urinary Bladder Cancer Mol. Cancer Ther., February 1, 2003; 2(2): 183 - 188. [Abstract] [Full Text] [PDF]

				D. M. Townsend, H. Shen, A. L. Staros, L. Gate, and K. D. Tew Efficacy of a Glutathione S-Transferase {pi}-activated Prodrug in Platinum-resistant Ovarian Cancer Cells Mol. Cancer Ther., October 1, 2002; 1(12): 1089 - 1095. [Abstract] [Full Text] [PDF]

				S. Alas, C.-P. Ng, and B. Bonavida Rituximab Modifies the Cisplatin-mitochondrial Signaling Pathway, Resulting in Apoptosis in Cisplatin-resistant Non-Hodgkin's Lymphoma Clin. Cancer Res., March 1, 2002; 8(3): 836 - 845. [Abstract] [Full Text] [PDF]

				V. M. Gonzalez, M. A. Fuertes, C. Alonso, and J. M. Perez Is Cisplatin-Induced Cell Death Always Produced by Apoptosis? Mol. Pharmacol., April 1, 2001; 59(4): 657 - 663. [Full Text]

				N. NASREEN, K. A. MOHAMMED, P. A. DOWLING, M. J. WARD, G. GALFFY, and V. B. ANTONY Talc Induces Apoptosis in Human Malignant Mesothelioma Cells In Vitro Am. J. Respir. Crit. Care Med., February 1, 2000; 161(2): 595 - 600. [Abstract] [Full Text]

				H. Shen, M. P. Schultz, and K. D. Tew Glutathione Conjugate Interactions with DNA-Dependent Protein Kinase J. Pharmacol. Exp. Ther., September 1, 1999; 290(3): 1101 - 1106. [Abstract] [Full Text]

				K. M. Henkels and J. J. Turchi Cisplatin-induced Apoptosis Proceeds by Caspase-3-dependent and -independent Pathways in Cisplatin-resistant and -sensitive Human Ovarian Cancer Cell Lines Cancer Res., July 1, 1999; 59(13): 3077 - 3083. [Abstract] [Full Text] [PDF]

				P. Frit, Y. Canitrot, C. Muller, N. Foray, P. Calsou, E. Marangoni, J. Bourhis, and B. Salles Cross-Resistance to Ionizing Radiation in a Murine Leukemic Cell Line Resistant to cis-Dichlorodiammineplatinum(II): Role of Ku Autoantigen Mol. Pharmacol., July 1, 1999; 56(1): 141 - 146. [Abstract] [Full Text]